Haleon Strengthens Control Of China JV, Agrees Option To Buy

Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.

• Source: Shutterstock

Haleon is beefing up its stake in Chinese OTC joint venture TSKF and has secured an option to take full control of the business in the future.

More from China

More from Asia